Arkema's Stock Rises 3.9% at the Close of January 22
On Thursday, January 22, specialty chemicals company Arkema showed a 3.9% increase to 52 euros, after closing at 50.05 euros the previous day. This rise comes in a context where the stock remains under pressure with a year-on-year decline of 30.25%. Investors are now closely monitoring technical signals and the divergent views of analysts, revealing a significant gap in expectations for the stock.
Divergent Analyst Recommendations
Recent recommendations on Arkema illustrate differing views on the stock. On January 20, Bernstein lowered its price target from 49 to 47 euros, reaffirming its underperformance rating. This target implies a potential downside of 9.6% from the current stock level. Conversely, UBS maintains a favorable position with a buy recommendation and a price target of 61 euros, revised down from 64 euros on January 14. This valuation gap reflects uncertainties weighing on the company in a deteriorated economic environment, notably marked by sluggish demand in Europe and the United States. In mid-January, Kepler Cheuvreux had already reduced its target from 63 to 59 euros, while maintaining its buy recommendation, indicating that several research firms are adjusting their forecasts in light of the economic situation. These successive revisions occur as the advanced materials specialist continues its strategy of focusing on higher value-added activities. The group is divesting some impact modifier and processing aid activities, used in the manufacture of technical plastics, to Indian company Praana. Meanwhile, Arkema has started a new Rilsan Clear transparent polyamide unit in Singapore, tripling its global capacity in promising markets such as electronics or medical devices. Despite these initiatives, the outlook remains constrained by a challenging macroeconomic context, with the group even planning to reduce its investments to around 600 million euros by 2026.
Technical Analysis of the Stock
Graphically, Arkema's stock is now trading at 52 euros, slightly above its 50-day moving average of 51.69 euros. This position indicates an attempt at stabilization after a turbulent stock market journey. However, resistance at 53.60 euros remains a short-term hurdle, while support at 48.46 euros is a vigilance threshold in case of a reversal. The Relative Strength Index (RSI) stands at 42 points, signaling no particular tension but also no marked bullish momentum. This neutral level falls within a range where the stock shows neither oversold nor overbought conditions. The one-month volatility is set at 9.53%, reflecting a moderate amplitude of fluctuations. The stock remains significantly below its 200-day moving average of 58.07 euros, illustrating an unfavorable underlying trend. This gap reflects the ongoing caution of investors in the face of sectoral challenges. The MACD histogram, negative at -0.38, confirms the absence of a confirmed bullish dynamic, although today's rebound could initiate a technical catch-up. In this context, operators will closely monitor the resistance threshold and the upcoming annual results expected on February 26, which could clarify the group's directions.
